LFST logo

LifeStance Health Group, Inc. Stock Price

NasdaqGS:LFST Community·US$4.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

LFST Share Price Performance

US$12.23
7.06 (136.56%)
US$12.90
Fair Value
US$12.23
7.06 (136.56%)
5.2% undervalued intrinsic discount
US$12.90
Fair Value
Price US$12.23
AnalystConsensusTarget US$12.90
AnalystHighTarget US$13.00
AnalystLowTarget US$9.00

LFST Community Narratives

·
Fair Value US$12.9 5.2% undervalued intrinsic discount

US Mental Health Demand And AI Will Expand Care Access

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value US$13 5.9% undervalued intrinsic discount

Digital Advancements And Telehealth Will Expand Mental Health Access

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$9 35.9% overvalued intrinsic discount

Digital Advances Will Strain Mental Health Care Yet Recovery Awaits

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$9
35.9% overvalued intrinsic discount
Revenue
13.84% p.a.
Profit Margin
5.96%
Future PE
32.29x
Price in 2029
US$11.04

Trending Discussion

No trending discussion available.

Updated Narratives

LFST logo

LFST: Buybacks And Raised Outlook Will Support Future Earnings And Cash Flow

Fair Value: US$12.9 5.2% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
LFST logo

LFST: Future Earnings Power Will Rely On Clinician Scale And Technology

Fair Value: US$13 5.9% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
LFST logo

LFST: Index Additions And Acquisitions Will Support Future Upside

Fair Value: US$9 35.9% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Reasonable growth potential with adequate balance sheet.

1 Risk
2 Rewards

LifeStance Health Group, Inc. Key Details

US$1.6b

Revenue

US$1.1b

Cost of Revenue

US$531.9m

Gross Profit

US$481.3m

Other Expenses

US$50.6m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.13
33.56%
3.19%
18.5%
View Full Analysis

About LFST

Founded
2017
Employees
8542
CEO
David Bourdon
WebsiteView website
lifestance.com

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Recent LFST News & Updates

Narrative Update Aug 12

LFST: Buybacks And Raised Outlook Will Support Future Earnings And Cash Flow

Analysts now set a revised fair value price target of $12.90 for LifeStance Health Group, compared with the prior $12.00. This reflects updated views on discount rates, revenue growth, profit margins, and future P/E assumptions.

Recent updates

No updates